LTRN

Lantern Pharma INC

-$4.1M

Net Activity

Institutions Holding

32

Popularity Rank

#7094

Avg Weight

0.08%

Total Value

$2.8M

Ownership Trend

32 institutions currently hold LTRN, with 11 net buyers and 13 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

13

Net Buying Institutions

11

Key Holders

View all 32 holding institutions

Quarterly Activity

Recent Activity

+$794.0K

Total Buy Value

$3.8M

Total Sell Value

New buy2
Trim8
Add9
Sold out5

11

Net Buyers

13

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding LANTERN PHARMA INC (LTRN)?
Major stakeholders currently include BIOS Capital Management, LP ($1.2M), Vanguard Capital Management LLC ($454.9K), CM Management, LLC ($342.5K). Based on the latest 13F filings, there are a total of 32 tracked investment funds and institutions maintaining positions in LTRN.
What is the overall institutional sentiment toward LTRN recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $4.1M, driven by 11 managers accumulating shares while 13 reduced their exposure.
Which institutions have been selling or reducing their LTRN positions?
In the latest period, 8 funds trimmed their holdings, and 5 managers completely exited their positions. The aggregate reported sell value was $3.8M.
Are there any notable investors adding LTRN to their portfolios?
Yes, buying activity remains notable. 2 institutions opened new positions in {ticker}, and 9 existing holders added to their shares. The total reported buy value for the quarter amounted to $794.0K.

Related Stocks